Results 141 to 150 of about 16,602 (194)

Local Tumor Response to Conventional Transarterial Chemoembolization following Seven-day Lenvatinib Administration. [PDF]

Interv Radiol (Higashimatsuyama)
Kageyama K, Uchida-Kobayashi S, Shinkawa H, Yamamoto A, Odagiri N, Kinoshita M, Nakano-Maebayashi M, Asano K, Fujii H, Enomoto M, Ishizawa T, Miki Y.   +11 more
europepmc   +1 more source

Uncommon Complication of Transarterial Chemoembolization with Doxorubicin: A Case of Post-TACE Neutropenia in Hepatocellular Carcinoma. [PDF]

Case Rep Oncol
Hajmusa M, Obaid KR, Abdalhadi AM, Mohamed S, Kanbour A.   +4 more
europepmc   +1 more source

Safety and efficacy of transcatheter arterial infusion chemotherapy combined with Lipiodol chemoembolization for advanced colorectal cancer with bleeding: a retrospective single-center clinical study of 119 patients in China. [PDF]

Quant Imaging Med Surg
Zhang J, Ma Y, Zhang S, Ma Y, He W, Wu G.   +5 more
europepmc   +1 more source

Integrating Combination Therapy and Smart Embolic Materials to Overcome the Therapeutic Ceiling of Transarterial Chemoembolization in Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Fu Y, Bai C, Ling Y, Liu Y, Li W, Li G.
europepmc   +1 more source

Marginal Contrast Saturation-Based Intraoperative Scoring System Predicts Objective Response to DEB-TACE: Development and Validation of a CBCT-Derived Real-Time Score. [PDF]

Cancer Med
Gao Z, Li B, Feng B, Sun C, Zang Y, Zhang X, Wang Y, Xin Q, Jia K, Lyu R.   +9 more
europepmc   +1 more source

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma

, 1993
openaire   +1 more source

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.
openaire  

Some of the next articles are maybe not open access.

Related searches:

The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma

Journal of Digestive Diseases, 2020
ObjectiveSystemic therapy, such as sorafenib, has been used clinically to treat patients with advanced stage or Barcelona Clinic Liver Cancer staging system (BCLC) stage C hepatocellular carcinoma (HCC). The aim of the study was to evaluate the therapeutic benefit of combined sorafenib and transarterial chemoembolization (TACE) in this group of ...
Shou Wu Lee, Teng Yu Lee, Yen Chun Peng, Sheng Shun Yang, Hong Zen Yeh, Chi Sen Chang   +5 more
openaire   +2 more sources

Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

CardioVascular and Interventional Radiology, 2022
To evaluate the preclinical in vivo therapeutic response of Lenvatinib-eluting microspheres (LEN-EM) transcatheter arterial chemoembolization (LEN-TACE) in an hepatocellular carcinoma (HCC) rat model.Magnetic resonance imaging (MRI) visible LEN-EM was fabricated with poly(lactide-co-glycolide) and iron oxide nanoparticles by a double-emulsion method ...
Jason Pe, Bongseo Choi, Hyunjun Choi, Soon Woo Kwon, Dong-Hyun Kim   +4 more
openaire   +2 more sources